Cyproheptadine Hydrochloride description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Cyproheptadine Hydrochloride

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

CYPROHEPTADINE HYDROCHLORIDE DESCRIPTION


Cyproheptadine Hydrochloride



CLINICAL PHARMACOLOGY


Pharmacokinetics and Metabolism:

INDICATIONS & USAGE










CYPROHEPTADINE HYDROCHLORIDE CONTRAINDICATIONS

Newborn or Premature Infants:
Nursing Mothers:
Other Conditions:








WARNINGS

Pediatric Patients:

CNS Depressants:
Activities Requiring Mental Alertness:

PRECAUTIONS

General:







INFORMATION FOR PATIENTS




DRUG INTERACTIONS





CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY





PREGNANCY

Category B


NURSING MOTHERS




PEDIATRIC USE




GERIATRIC USE




Central Nervous System
Integumentary:
Special Senses:
Cardiovascular:
Hematologic:
Digestive System:
Genitourinary:
Respiratory:
Miscellaneous:

OVERDOSAGE










DOSAGE & ADMINISTRATION



Pediatric Patients:
Age 2 to 6 years:


Age 7 to 14 years:
Adults:

HOW SUPPLIED




STORAGE AND HANDLING







PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Cyproheptadine Hydrochloride

Cyproheptadine Hydrochloride

Cyproheptadine Hydrochloride

Cyproheptadine Hydrochloride TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-781(NDC:60258-850)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
CYPROHEPTADINE HYDROCHLORIDE CYPROHEPTADINE 4 mg

Inactive Ingredients

Ingredient Name Strength
cellulose, microcrystalline
lactose monohydrate
MAGNESIUM STEARATE
SODIUM STARCH GLYCOLATE TYPE A POTATO

Product Characteristics

Color Size Imprint Code Shape
white 7 mm CYP ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-781-02 30 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA040644 2011-09-20


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.